Royal Bank Of Canada Catalyst Pharmaceuticals, Inc. Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 159,012 shares of CPRX stock, worth $3.21 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

159,012

Previous 73,358 116.76%

Holding current value

$3.21 Million

Previous $1.14 Million 178.26%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$15.19 - $21.35 $1.3 Million - $1.83 Million	85,654 Added 116.76%	159,012 $3.16 Million
Q2 2024 Aug 14, 2024	BUY	$14.68 - $16.92 $109,777 - $126,527	7,478 Added 11.35%	73,358 $1.14 Million
Q1 2024 Nov 05, 2024	SELL	$13.18 - $17.11 $98,560 - $127,948	-7,478 Reduced 10.19%	65,880 $1.05 Million
Q1 2024 May 15, 2024	SELL	$13.18 - $17.11 $314,474 - $408,244	-23,860 Reduced 26.59%	65,880 $1.05 Million
Q4 2023 Feb 14, 2024	BUY	$11.78 - $17.29 $148,121 - $217,404	12,574 Added 16.29%	89,740 $1.51 Million
Q3 2023 Nov 14, 2023	SELL	$11.69 - $15.02 $139,905 - $179,759	-11,968 Reduced 13.43%	77,166 $902,000
Q2 2023 Aug 14, 2023	BUY	$11.5 - $18.08 $77,326 - $121,569	6,724 Added 8.16%	89,134 $1.2 Million
Q1 2023 May 15, 2023	SELL	$14.34 - $21.05 $85,036 - $124,826	-5,930 Reduced 6.71%	82,410 $1.37 Million
Q4 2022 Feb 14, 2023	BUY	$12.25 - $19.5 $488,334 - $777,348	39,864 Added 82.23%	88,340 $1.64 Million
Q3 2022 Nov 14, 2022	BUY	$7.06 - $15.52 $43,454 - $95,525	6,155 Added 14.54%	48,476 $622,000
Q2 2022 Aug 15, 2022	SELL	$6.23 - $8.57 $33,218 - $45,695	-5,332 Reduced 11.19%	42,321 $297,000
Q1 2022 May 16, 2022	SELL	$5.31 - $8.31 $67,893 - $106,251	-12,786 Reduced 21.16%	47,653 $394,000
Q4 2021 Feb 14, 2022	BUY	$5.21 - $7.45 $51,235 - $73,263	9,834 Added 19.43%	60,439 $410,000
Q3 2021 Nov 15, 2021	SELL	$4.85 - $6.04 $475,940 - $592,717	-98,132 Reduced 65.98%	50,605 $269,000
Q2 2021 Aug 16, 2021	BUY	$4.29 - $6.05 $638,081 - $899,858	148,737 New	148,737 $855,000

Others Institutions Holding CPRX

# of Institutions

325

Shares Held

94.1M

Call Options Held

19.1K

Put Options Held

51.1K

View Full List

About CATALYST PHARMACEUTICALS, INC.

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.08B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

More about CPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Catalyst Pharmaceuticals, Inc. Transaction History